http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006059121-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44f53bb6f168358e0b51f65e68235737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cfe9867ae503fc004ee036d871d4e93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e842a2577b3d164db7ede6a009f6af9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81c150af8961fd5ae4f74c3565019f3d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
filingDate 2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1358e395ed1b6e59d43f9869f53471f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba36f5162e16ba638cc7fe4c45bf42ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ffcaf9c56462f297ca3df954474325c
publicationDate 2007-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006059121-A3
titleOfInvention Modulators of spindle checkpoint kinases and a taxol
abstract The invention disclosed relates to spindle checkpoint kinase modulators, especially modulators of Mps 1 kinase which may be useful in the treatment and diagnosis of disease, such as cancer. Pharmaceutical compositions and treatments are disclosed comprising a modulator of Mps l kinase activity and a taxol .
priorityDate 2004-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314

Total number of triples: 32.